Triple Hair | Corporate and science news

Publications

Corporate, science and informational news

Keep up to date with the latest developments at Triple Hair! Check out our various publications to stay abreast of our scientific advances and the company’s growth.

All ALOPECIA Corporate In the medias Science

April 2, 2026

Corporate

Triple Hair Doses First Patient in Phase III Clinical Trial in Canada for Male Androgenic Alopecia

March 25, 2026

In the medias

Triple Hair’s Feature in the NY Post

June 23, 2025

Corporate

Triple Hair Group Signs Licensing Agreement for the Brazilian Market with Aché

May 28, 2025

Corporate

Triple Hair Group Strengthens Leadership Team with Appointment of Paul Sowyrda to its Board of Directors

April 8, 2025

Science

TH07 Clinical Study Featured in Peer-Reviewed Scientific Journal

October 23, 2024

Corporate

Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in India

June 19, 2024

Corporate

Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe

June 11, 2024

In the medias

Triple Hair’s Feature in Le Journal de Montréal

June 3, 2024

Corporate

Triple Hair Group Closes $4 Million Financing

February 12, 2024

Corporate

Triple Hair Doses First Patient in Phase III Clinical Trial in Canada for Male Androgenic Alopecia

Triple Hair’s Feature in the NY Post

Triple Hair Group Signs Licensing Agreement for the Brazilian Market with Aché

Triple Hair Group Strengthens Leadership Team with Appointment of Paul Sowyrda to its Board of Directors

TH07 Clinical Study Featured in Peer-Reviewed Scientific Journal

Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in India

Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe

Triple Hair’s Feature in Le Journal de Montréal

Triple Hair Group Closes $4 Million Financing

Triple Hair Wins “Jury’s Choice Award” at Octane Aesthetic Tech Forum